flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Patients with type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with would mitigate these risks is unknown. SGLT2 Inhibitors in the Management
Description
The Department of Veterans Affairs covers the medications for weight loss for veterans who already have tried less-pricey medications without success
Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, et al
J Am Coll Cardiol 62:263271
Although the mechanism remains unclear, this case supports the notion that GLP-1 receptor agonists may have broader thyroidal effects beyond neoplasia, possibly through subtle immune or endocrine modulation
Be careful about diet culture with a cute spin and a bow on it
However, it's important to use these supplements in moderation and choose products that are low in added sugars and unhealthy fats
